University of California, San Francisco, California 94115, USA.
Account Res. 2010 Sep;17(5):264-9. doi: 10.1080/08989621.2010.511568.
Determining the distribution of psychiatric disorders and developing sound preventive and intervention practices are pressing public health issues. Since at present mental disorders lack biological markers, psychiatric taxonomies must grapple with how best to address issues of validity and reliability. With the increasing congruence between the International Classification of Diseases (ICD-11) and the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) (American Psychiatric Association, 2010), it is imperative that decisions regarding the inclusion of new disorders be research-based and not unduly influenced by industry. The first draft of DSM-V, recently made public, has created a firestorm of controversy, for the DSM's nomenclature of disease or other pathology not only affects such disparate domains as jurisprudence and insurance claims but is also an instrument designed to facilitate research on psychopathology.
确定精神障碍的分布并制定健全的预防和干预措施是紧迫的公共卫生问题。由于目前精神障碍缺乏生物学标志物，精神疾病分类必须努力解决最佳解决有效性和可靠性问题。随着《国际疾病分类》（ICD-11）和《精神障碍诊断与统计手册》（DSM-V）（美国精神病学协会，2010）之间的一致性不断增强，关于纳入新疾病的决定必须基于研究，而不受行业的不当影响。最近公布的 DSM-V 的初稿引起了轩然大波，因为 DSM 的疾病命名或其他病理学不仅影响到法理学和保险索赔等截然不同的领域，而且还是一种旨在促进精神病理学研究的工具。
